Pharma & Bio
Latest Content
Just 1 in 5 pharma firms ‘risk ready’ in weeks before Gulf conflict, says report
Barely more than one in five major pharma firms were conducting risk assessment for global threats, says a survey conducted just weeks before the outbreak of the Gulf conflict.
Industry Update
Metrohm launches 2060 RISE: Inline Raman spectroscopy for smarter process control
Metrohm is proud to introduce the 2060 RISE (Raman Intelligent SEnsor), its new generation inline Raman spectrometer developed to drive real-time process monitoring and asset intelligence for industr…
Editor's comment
'Interesting times' beckon for pharma and biotech
The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.
Comment & Features
How load bank testing prevents pharmaceutical manufacturing downtime
When a single interruption can destabilise controlled systems, jeopardise batch integrity or delay time-critical medicines, preventing disruption is as important as resolving it. Andrew Keith explain…
Analysis
Case study: New cleanrooms prompt search for better monitoring system
During preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring…
